Browse Category

NYSE:UNH 19 January 2026 - 27 January 2026

UnitedHealth stock tumbles nearly 20% as Medicare Advantage rate proposal rattles UNH investors

UnitedHealth stock tumbles nearly 20% as Medicare Advantage rate proposal rattles UNH investors

UnitedHealth shares fell 18.4% to $286.96 Tuesday after a U.S. proposal signaled Medicare Advantage payments would rise just 0.09% in 2027. The company warned of its first revenue drop since 1989 despite maintaining its 2026 profit outlook. CVS Health and Humana also posted sharp declines. CMS will accept comments on the proposed rates through Feb. 25.
27 January 2026
Dow Jones drops 450 points as UnitedHealth sinks on Medicare rates; confidence slumps

Dow Jones drops 450 points as UnitedHealth sinks on Medicare rates; confidence slumps

The Dow Jones fell 445 points, or 0.9%, to 48,966 in early trading, dragged down by a 20% plunge in UnitedHealth after weak Medicare payment proposals and a downbeat 2026 forecast. U.S. consumer confidence dropped to its lowest since 2014. The S&P 500 and Nasdaq rose, while Humana and CVS also tumbled. Traders watched for earnings and the Fed meeting starting Tuesday.
27 January 2026
Wall Street futures rise ahead of Fed decision as Medicare rate plan hits insurers, earnings roll in

Wall Street futures rise ahead of Fed decision as Medicare rate plan hits insurers, earnings roll in

S&P 500 and Nasdaq futures rose early Tuesday, while Dow futures slipped, weighed by UnitedHealth after Washington proposed keeping Medicare Advantage payments nearly flat for 2027. Insurers fell in premarket trading. Investors awaited earnings reports and the Federal Reserve’s policy decision due Wednesday. Salesforce shares gained on news of a $5.6 billion U.S. Army contract.
Dow Jones futures slip as UnitedHealth tumbles on Medicare rates, Fed and earnings loom

Dow Jones futures slip as UnitedHealth tumbles on Medicare rates, Fed and earnings loom

Dow futures fell 40 points premarket Tuesday as UnitedHealth dropped 8.6% after a proposed Medicare Advantage rate increase came in far below expectations. S&P 500 and Nasdaq futures rose ahead of major earnings reports and the start of the Federal Reserve meeting. Salesforce gained 2.2% after landing a $5.6 billion U.S. Army contract. A partial government shutdown loomed with funding set to expire after midnight Friday.
UnitedHealth stock slides premarket as Medicare Advantage rate plan shakes insurers before earnings

UnitedHealth stock slides premarket as Medicare Advantage rate plan shakes insurers before earnings

UnitedHealth shares fell 8.3% to $322.32 in premarket trading after CMS proposed a near-flat 0.09% average payment increase for 2027 Medicare Advantage plans and stricter rules on diagnosis data. The move triggered a broad selloff in managed-care stocks, with CVS Health and Humana also dropping sharply. UnitedHealth is set to report earnings and its 2026 outlook before the market opens. CMS will accept comments on the proposal until Feb. 25.
UnitedHealth (UNH) stock slides after-hours as CMS proposes near-flat 2027 Medicare Advantage payments

UnitedHealth (UNH) stock slides after-hours as CMS proposes near-flat 2027 Medicare Advantage payments

UnitedHealth shares fell over 10% in after-hours trading Monday after U.S. officials proposed a 0.09% average payment increase for Medicare Advantage plans in 2027. The Centers for Medicare & Medicaid Services also outlined changes to risk adjustment, including limits on payments tied to certain chart reviews. CVS Health and Humana shares dropped as much as 15%. UnitedHealth reports earnings and 2026 guidance Tuesday morning.
27 January 2026
Dow Jones rises today as Fed decision and Big Tech earnings set the tone for Wall Street

Dow Jones rises today as Fed decision and Big Tech earnings set the tone for Wall Street

The Dow Jones Industrial Average rose 185.35 points, or 0.38%, to 49,284.06 by 10:32 a.m. EST, led by gains in Apple and Cisco. UnitedHealth and Boeing slipped, limiting the advance. Gold surged past $5,100 an ounce, setting a new record. Investors await the Federal Reserve meeting starting Tuesday and a U.S. funding deadline on Jan. 30.
Healthcare stocks brace for a key week: XLV slips as Wegovy pill data and UnitedHealth earnings loom

Healthcare stocks brace for a key week: XLV slips as Wegovy pill data and UnitedHealth earnings loom

The Health Care Select Sector SPDR Fund (XLV) fell 0.5% to $157.48 Friday, with Eli Lilly down 2.1%. Johnson & Johnson and UnitedHealth posted small gains. Traders are watching obesity-drug demand and a crowded earnings calendar next week. The FDA linked ByHeart’s recalled infant formula to a multi-state botulism outbreak.
Healthcare stocks brace for a busy week as XLV slips, UnitedHealth earnings and Capitol Hill heat loom

Healthcare stocks brace for a busy week as XLV slips, UnitedHealth earnings and Capitol Hill heat loom

XLV fell 0.51% to $157.48 Friday, trailing the S&P 500, which ended flat. Health insurer CEOs faced House scrutiny over rising premiums and consolidation, with UnitedHealth pledging ACA rebates in 2026. UnitedHealth reports earnings Jan. 27, Regeneron on Jan. 30. Corcept Therapeutics jumped 45% after positive ovarian cancer trial results.
UnitedHealth stock price edges up after-hours as ACA rebate pledge keeps UNH in focus

UnitedHealth stock price edges up after-hours as ACA rebate pledge keeps UNH in focus

UnitedHealth shares rose about 0.5% in after-hours trading Friday, closing at $356.26. The move followed CEO Stephen Hemsley’s announcement that the company will rebate profits from its Obamacare plans as Congress scrutinizes insurer practices. Lawmakers questioned UnitedHealth and other major insurers on Capitol Hill over rising costs. Investors await UnitedHealth’s earnings report and 2026 guidance on Jan. 27.
24 January 2026
UnitedHealth stock price today: UNH steadies near $355 after Obamacare rebate pledge, with earnings next week

UnitedHealth stock price today: UNH steadies near $355 after Obamacare rebate pledge, with earnings next week

UnitedHealth shares rose 0.2% to $355.19 in late morning trading Friday after the company pledged to rebate ACA marketplace profits in 2026. The move follows a contentious Capitol Hill hearing on insurer competition and rising premiums. Investors await UnitedHealth’s January 27 earnings and 2026 outlook for signals on medical costs.
Why UnitedHealth Group (UNH) stock rose today as Obamacare rebates and earnings loom

Why UnitedHealth Group (UNH) stock rose today as Obamacare rebates and earnings loom

UnitedHealth shares rose 1.96% to $354.47 Thursday as investors focused on the insurer’s plan to rebate ACA profits starting in 2026. CEO Stephen Hemsley faced lawmakers over rising insurance costs, while analysts await the company’s Jan. 27 results and 2026 outlook. ACA premiums are projected to more than double next year, with enrollment expected to fall by two-thirds.
Dow Jones rebounds as Trump rules out force on Greenland; tariffs still hang over Wall Street

Dow Jones rebounds as Trump rules out force on Greenland; tariffs still hang over Wall Street

The Dow Jones rose about 0.6% Wednesday, recovering nearly 297 points after President Trump ruled out using force to acquire Greenland. Tuesday saw the index plunge 870 points following new U.S. tariffs on European goods. Merck and UnitedHealth led early gains, while IBM and 3M dragged on the previous session. Investors await jobless claims data Thursday and the Fed meeting next week.
Dow Jones rebounds after Tuesday’s 870-point hit as Trump cools Greenland talk

Dow Jones rebounds after Tuesday’s 870-point hit as Trump cools Greenland talk

The Dow Jones rose 203 points to 48,692.15 early Wednesday, rebounding after Tuesday’s 870-point drop triggered by Trump’s tariff threats on eight European countries. Healthcare stocks led gains, with Merck and UnitedHealth adding about 40 points. The Supreme Court began hearing arguments on Trump’s bid to fire Fed Governor Lisa Cook. A Reuters poll showed economists expect the Fed to hold rates steady this quarter.
UnitedHealth stock back in focus: Bernstein sticks with $444 target as UNH earnings near

UnitedHealth stock back in focus: Bernstein sticks with $444 target as UNH earnings near

UnitedHealth shares closed down 2.3% at $331.02 Friday as Bernstein reiterated an Outperform rating and $444 target, citing potential margin recovery in Medicare Advantage and Medicaid. The company reports earnings and 2026 guidance Jan. 27, with investors focused on medical costs and outlook. U.S. lawmakers will question UnitedHealth’s CEO Jan. 22 on coverage affordability. Markets reopen Tuesday after the holiday.
1 2 3 4 5 9
Go toTop